Skip to main content

Heiner Dreismann

Nucleix has appointed Heiner Dreismann to the company's board of directors. Currently, he serves on the boards of several public and private healthcare companies. From 1985 to 2006, Dreismann has held several senior positions at the Roche Group, including president and CEO of Roche Molecular Systems, head of global business development at Roche Diagnostics and a member of Roche's global diagnostic executive committee.

The Scan

Call to Look Again

More than a dozen researchers penned a letter in Science saying a previous investigation into the origin of SARS-CoV-2 did not give theories equal consideration.

Not Always Trusted

In a new poll, slightly more than half of US adults have a great deal or quite a lot of trust in the Centers for Disease Control and Prevention, the Hill reports.

Identified Decades Later

A genetic genealogy approach has identified "Christy Crystal Creek," the New York Times reports.

Science Papers Report on Splicing Enhancer, Point of Care Test for Sexual Transmitted Disease

In Science this week: a novel RNA structural element that acts as a splicing enhancer, and more.